Last reviewed · How we verify
Gonal-f®: follitropin alpha — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Gonal-f®: follitropin alpha (Gonal-f®: follitropin alpha) — Centre Hospitalier Chretien.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Gonal-f®: follitropin alpha TARGET | Gonal-f®: follitropin alpha | Centre Hospitalier Chretien | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Gonal-f®: follitropin alpha CI watch — RSS
- Gonal-f®: follitropin alpha CI watch — Atom
- Gonal-f®: follitropin alpha CI watch — JSON
- Gonal-f®: follitropin alpha alone — RSS
Cite this brief
Drug Landscape (2026). Gonal-f®: follitropin alpha — Competitive Intelligence Brief. https://druglandscape.com/ci/gonal-f-follitropin-alpha. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab